 |
|
| 3WIN | | 3WIN is an early stage venture in the active implantable medical device industry.
The company is pursuing to add high-tech innovative solutions to the field.
The founders of 3WIN have been pioneers in the cochlear implant industry.
The 3WIN-team consists of highly trained and experienced R&D and production engineers, clinical and marketing experts.
3WIN has an on-site-state-of-the-art workshop and clean room, with high tech equipment, for development and production of active  |
|
|
|
| Addestino Innovation Management | | Our customers work with us because we help them creating profitable growth, from idea till results by:
* Making winning choices. 'Fuzzy market environments, limited budgets : which are the right opportunities to aim for ?'
* Delivering fast, user-centric innovation. 'Success is 1% inspiration, 99% transpiration: how to get to market fast?'
* Providing talent on-demand: 'Innovation requires new multidisciplinary skills: where and how to acquire these now?'
|
|
|
|
|
|
| AVEVE | | Onze business
Groep Aveve is marktleider in de toelevering aan de land- en tuinbouw in België en heeft de grootste tuincentrumketen van het land. Groep Aveve bestaat uit een veertigtal bedrijven, die systematisch samenwerken. De uitwisseling van informatie en kennis, de bundeling van onderzoek en ontwikkeling én de gezamenlijke aankoop van producten en diensten dragen bij tot een maximaal rendement van elk bedrijf afzonderlijk. Personeelsbestand: 1.600 mensen. Zakencijfer: 900 miljoen euro.
|
|
|
|
| Better3fruit | | | Better3fruit is a world leader in the breeding of hard fruit varieties (apple and pear). The company is strongly involved in creating managed concepts ('clubs') for the introduction of new varieties in the market. Its flagship products are the new apples Greenstar and Kanzi. |
|
|
|
|
|
| eSaturnus | | | eSaturnus is an advanced technology provider for digital signal processing and multimedia solutions within and beyond modern operating rooms. |
|
|
|
|
|
|
|
| Gent BC | | Gent BC (Big in Creativity) is an online and real life network fostering knowledge based industry, entrepreneurship and innovation in the region of Ghent.
On-line network: via the website you will have access to news and events related to innovation and knowledge based industries in the region of Ghent.
Real-life network: Gent BC organises networking events around innovation and entrepreneurship. |
|
|
|
| imec | | | Imec performs world-leading research in nanoelectronics. Imec leverages its scientific knowledge with the innovative power of its global partnerships in ICT, healthcare and energy. |
|
|
|
| Inforstat | | Statistical treatment is an instrument contributing to the right decision in the realization of your projects.
Inforstat, a company specialized in statistical consulting, helps you designing your experiments or surveys, organizes your data, presents and analyses those with the most appropriate statistical methods.
|
|
|
|
| Innovatiesteunpunt voor Land-en Tuinbouw | | Het Innovatiesteunpunt voor land- en tuinbouw is dé gespecialiseerde dienst voor inventieve boeren en tuinders in Vlaanderen. Bedrijfsleiders kunnen er terecht voor informatie, advies, begeleiding en vorming.
|
|
|
|
|
|
|
|
| PROVAXS | | | PROVAXS is the coordinating center of a network of laboratories of the University of Ghent that unite their expertise in the development of veterinary and human vaccines, therapeutics and diagnostics. |
|
|
|
| reMYND NV | | reMYND actively drives the development of disease modifying treatments against Alzheimer's Disease (AD) and Parkinson's Disease (PD), either as a Contract Research Organisation (CRO) or through its own Drug Discovery&Development.
|
|
|
|
|
|
| ThromboGenics NV | | | ThromboGenics is a biopharmaceutical company focused on the development of therapeutics for conditions related to the vascular system. The Company has used its in house expertise to build a significant pipeline of promising drug candidates, a number of which are in clinical trials. The Company is focused on developing new medicines to treat visual disorders, cardiovascular diseases, and cancer, conditions which result from abnormalities to the vascular system. ThromboGenics' lead product is |
|
|
|
| Tigenix | | TiGenix is a public listed, late-stage biomedical company that focuses on innovative local treatments for damaged and osteoarthritic joints. Based in Leuven, Belgium, TiGenix was founded in 2000 as a spin-off from the the Katholieke Universiteit Leuven and the Universiteit Gent.
|
|
|
Contact